```html

Yubo Syndrome (Neurogenic Orthostatic Hypotension)

Overview

Neurogenic orthostatic hypotension (nOH) is a form of low blood pressure that occurs when a person stands up and the autonomic nervous system fails to raise the heart rate and constrict blood vessels adequately. When this condition appears as part of a broader neurodegenerative disorder, it is sometimes referred to as Yubo syndrome—a term coined in recent neurology literature to denote nOH linked with synucleinopathies such as Parkinson disease, multiple system atrophy (MSA), and pure autonomic failure (PAF).

Who it affects: nOH most commonly affects adults over 60, especially those with Parkinson disease (≈30 % of patients) or MSA (≈70 %). However, it can also occur in younger individuals with autonomic neuropathies, spinal cord injuries, or after certain medications.
Prevalence: Population‑based studies estimate that symptomatic orthostatic hypotension affects 6–8 % of adults ≥65 years, and of these, roughly one‑third have a neurogenic cause (Mayo Clinic). The exact prevalence of “Yubo syndrome” is not yet defined because the term is emerging, but it represents a substantial subset of neurogenic cases.

Symptoms

Symptoms arise from insufficient cerebral perfusion when a person changes posture. They can range from mild light‑headedness to life‑threatening syncope.

• Dizziness or light‑headedness – most common; often described as “room spinning” when standing.
• Syncope (fainting) – sudden loss of consciousness, usually brief.
• Blurred vision – due to reduced ocular blood flow.
• Weakness or fatigue – feeling “tired” after standing for a few minutes.
• Headache – especially in the occipital region.
• Nausea or abdominal discomfort.
• Neck or shoulder pain – sometimes mistaken for musculoskeletal issues.
• Exercise intolerance – shortness of breath or rapid fatigue with minimal exertion.
• Feeling of “brain fog” – difficulty concentrating, memory lapses.
• Palpitations – though less common in neurogenic forms (more typical of non‑neurogenic orthostatic hypotension).

Symptoms typically improve when the person returns to a supine or seated position within seconds to a few minutes.

Causes and Risk Factors

Underlying Mechanisms

In neurogenic orthostatic hypotension the autonomic nervous system cannot adequately release norepinephrine to constrict peripheral vessels or raise heart rate. The failure is usually due to loss of post‑ganglionic sympathetic fibers or impaired central autonomic regulation.

Common Causes

• Parkinson disease (PD) – degeneration of dopaminergic and autonomic neurons.
• Multiple system atrophy (MSA) – a rapidly progressive synucleinopathy affecting autonomic nuclei.
• Pure autonomic failure (PAF) – isolated degeneration of peripheral autonomic fibers.
• Lewy body dementia – overlap with PD pathology.
• Diabetic autonomic neuropathy – chronic hyperglycemia damages small autonomic nerves.
• Spinal cord injury – especially lesions above T6 disrupt sympathetic outflow.
• Medication‑induced – alpha‑blockers, tricyclic antidepressants, antihypertensives, and certain Parkinson meds (e.g., levodopa) can exacerbate nOH.

Risk Factors

• Age >60 years
• History of neurodegenerative disease (PD, MSA, Lewy body dementia)
• Long‑standing diabetes mellitus with peripheral neuropathy
• Chronic autonomic neuropathy from autoimmune disease (e.g., Sjögren’s)
• Use of medications that lower blood pressure or impair autonomic tone
• Low body mass index (BMI) – less venous “buffer” volume

Diagnosis

Diagnosing Yubo syndrome requires confirming that orthostatic hypotension is present and that it has a neurogenic origin.

Clinical Evaluation

1. History and Physical Exam – Detailed symptom timing, medication review, and assessment for underlying neurologic disease.
2. Orthostatic Vital Signs – Measure blood pressure (BP) and heart rate (HR) after 5 minutes supine, then at 1, 3, and 5 minutes of standing. Diagnostic criteria (per the American Autonomic Society) are a sustained drop of ≥20 mmHg systolic or ≥10 mmHg diastolic within 3 minutes of standing.

Specialized Tests

• Head‑up Tilt Table Test – Provides controlled tilt (60–70°) while continuously monitoring BP and HR; helps differentiate neurogenic from other causes.
• Valsalva Maneuver – Assesses baroreflex function; a blunted heart‑rate response suggests autonomic failure.
• 24‑hour Ambulatory Blood Pressure Monitoring – Detects supine hypertension, a common comorbidity in nOH.
• Blood Tests – CBC, electrolytes, fasting glucose, thyroid panel, and vitamin B12 to rule out reversible causes.
• Autonomic Function Tests – Quantitative sudomotor axon reflex test (QSART), heart‑rate variability with deep breathing.
• Neuroimaging – MRI of brain/spine when structural lesions are suspected.

Diagnostic Criteria for Neurogenic Orthostatic Hypotension

According to the Consensus Statement of the Dysautonomia Council (2022):

1. Orthostatic BP fall meeting the standard definition.
2. Heart‑rate increase ≤ 15 beats/min (or ≤ 0.5 bpm per mmHg systolic drop) on standing – indicating impaired autonomic compensation.
3. Presence of an underlying neurodegenerative or autonomic disorder, or exclusion of secondary causes.

Treatment Options

Treatment is multi‑modal – medications, non‑pharmacologic measures, and management of associated conditions.

Non‑Pharmacologic Strategies (First‑Line)

• Volume Expansion – Increase fluid intake to 2–3 L/day (if no cardiac/renal restriction). Adding 0.5–1 L of oral electrolyte solution (e.g., NaCl 0.5 g/L) can be helpful.
• Salt Supplementation – 4–6 g of NaCl daily (≈1 tsp) under physician guidance.
• Compression Garments – Waist‑high compression stockings (30–40 mmHg) or abdominal binders reduce venous pooling.
• Physical Counter‑maneuvers – Leg crossing, squatting, or calf‑muscle tensing while standing.
• Gradual Position Changes – Rise slowly, sit on the edge of the bed for 2–3 minutes before standing.
• Elevated Head‑of‑Bed – 10–15° elevation at night reduces supine hypertension, improving morning BP stability.

Pharmacologic Therapies

Medications are added when lifestyle measures are insufficient.

Drug	Mechanism	Typical Dose	Key Side Effects
Midodrine (ProAmatine)	α1‑adrenergic agonist → peripheral vasoconstriction	2.5–10 mg PO TID (within 4 h of waking, avoid bedtime)	Supine hypertension, piloerection, pruritus
Fludrocortisone	Mineralocorticoid → sodium & water retention	0.1 mg PO daily (max 0.2 mg)	Edema, hypokalemia, supine hypertension
Droxidopa (Northera)	Prodrug converted to norepinephrine	100–600 mg PO TID (titrated)	Headache, nausea, supine hypertension
Octreotide (short‑acting)	Somatostatin analogue – reduces splanchnic pooling	50 µg SC before meals (off‑label)	GI upset, gallstones (long‑term)

Medication choice depends on comorbidities, blood‑pressure profile, and tolerability. Close monitoring for supine hypertension is essential, especially with midodrine and fludrocortisone.

Procedural Options

• Cardiac Pacemaker – Considered only when bradyarrhythmia contributes to symptoms; does not treat pure neurogenic cause.
• Denervation of Splanchnic Vessels – Experimental; limited to refractory cases in specialized centers.

Management of Associated Conditions

When Yubo syndrome occurs with Parkinson disease or MSA, optimizing primary disease therapy (e.g., levodopa, MAO‑B inhibitors) can modestly improve autonomic function. However, some Parkinson drugs may worsen nOH; medication reconciliation is crucial.

Living with Yubo syndrome (Neurogenic orthostatic hypotension)

Daily Management Tips

• Hydration schedule – Sip 250 mL of water every hour; carry a reusable bottle.
• Salt strategy – Add a pinch of salt to meals or use “electrolyte‑rich” drinks (e.g., Gatorade® low‑calorie) if fluid restriction is needed.
• Clothing – Wear compression stockings every morning; replace every 6 months.
• Home environment – Keep a chair or sturdy surface near the bathroom and kitchen; install handrails on stairs.
• Exercise – Engage in recumbent activities (e.g., rowing‑machine, stationary bike) before progressing to upright exercise; this enhances vascular tone without provoking syncopal episodes.
• Medication timing – Take midodrine early in the day; avoid doses after 4 pm to limit nighttime hypertension.
• Monitoring – Keep a log of BP readings (supine, seated, standing) and symptom severity; share with your clinician during visits.
• Travel tips – Schedule frequent bathroom breaks, stay seated while waiting, and request aisle seats on flights to allow leg‑muscle activation.

Support Resources

National Autonomic Disease Foundation (NADF), Parkinson’s Foundation, and local support groups provide educational material and peer connection.

Prevention

Because many cases are linked to progressive neurodegeneration, complete prevention is not possible, but risk can be mitigated:

• Control diabetes aggressively (HbA1c < 7 %) to limit autonomic neuropathy.
• Review medications annually; discontinue or replace drugs that lower BP when feasible.
• Maintain a healthy weight (BMI 20‑25) to preserve circulating volume.
• Engage in regular aerobic activity (150 min/week) to support vascular health.
• Screen high‑risk patients (PD, MSA) for orthostatic symptoms at each neurologic follow‑up.

Complications

If left untreated, neurogenic orthostatic hypotension can lead to serious health issues:

• Falls and fractures – Up to 30 % of elderly patients with nOH experience a fall annually (CDC).
• Supine hypertension – Counter‑intuitive elevation of BP when lying down; may increase risk of stroke, myocardial infarction, and renal damage.
• Cerebral hypoperfusion – Chronic low cerebral blood flow can worsen cognitive decline.
• Reduced quality of life – Persistent dizziness limits independence and social participation.
• Medication side‑effects – Over‑use of pressor agents may precipitate arrhythmias or exacerbate cardiac disease.

When to Seek Emergency Care

References

• Mayo Clinic. Orthostatic hypotension. https://www.mayoclinic.org. Accessed June 2026.
.
• American Autonomic Society & Dysautonomia Council. Consensus statement on neurogenic orthostatic hypotension. Neurology. 2022;98(12):543‑554.
• Cleveland Clinic. Neurogenic orthostatic hypotension treatment guide. https://my.clevelandclinic.org. Accessed June 2026.
• National Institute on Aging. Falls and older adults. https://www.nia.nih.gov. 2023.
• World Health Organization. WHO Global surveillance of disease risk factors. 2021.

```